How To Create Value And Why Pressure Is A Privilege With Ted Karkus CEO ProPhase Labs - $PRPH

Ted Karkus CEO & Chairman Of The Board Of ProPhase Labs $PRPH


 


Ticker: PRPH


 


Website:


https://www.prophaselabs.com/





Bio:


Ted Karkus


Chairman & CEO of ProPhase Labs





Ted Karkus, CEO and Chairman of ProPhase Labs, drives the
company’s diverse and synergistic businesses with his successful
track record in biomedical and health companies. He transformed
ID Biomedical’s strategy and valuation from $25 million to $1.4
billion sale to GlaxoSmithKline. As CEO of ProPhase Labs, he
restructured the go-to-market strategy for the flagship product
Cold-EEZE, turned around and significantly grew revenues,
ultimately selling it for $50 million to Mylan.


ProPhase Labs is a fast-growing biotech, genomics and diagnostics
company due to its commitment to growth, innovation, and
execution excellence outlined in Ted’s high growth roadmap. He
pivoted into industry leading CLIA labs, and then further
diversified by acquiring genomics leader Nebula Genomics.
Constantly innovating, Ted then created ProPhase BioPharma to
deliver antivirals, cancer tests and therapeutic cancer
compounds. The new acquisitions and legacy businesses work to
drive synergistic growth with multi-billion-dollar potential.


He holds a BS in Psychology from Tufts University with Magna Cum
Laude Honors and an MBA in Finance from Columbia University
School of Business with Beta Gamma Sigma Honors.